News

PharmExec4h
FDA Grants Accelerated Approval to Boehringer Ingelheim’s Hernexeos for Unresectable or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Accelerated approval was based on results from the Phase Ib Beamion-LUNG 1 trial (NCT04886804), which showed a 75% objective ...
PharmExec9h
Bridging the Gap Between AI-Powered Medical Imaging and Clinical Decision-Making in Precision Oncology: Are we there yet?
Today, imaging often exists independently of molecular insights, trial data, treatment decisions, and longitudinal patient ...